Mascoma Wealth Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.61K | Hold |
100
| – | – | ﹤0.01% | 336 |
|
|
2026
Q1 | $9.04K | Hold |
100
| – | – | ﹤0.01% | 329 |
|
|
2025
Q4 | $8.99K | Hold |
100
| – | – | ﹤0.01% | 325 |
|
|
2025
Q3 | $9.85K | Hold |
100
| – | – | ﹤0.01% | 329 |
|
|
2025
Q2 | $9.12K | Sell |
100
-20
| -17% | -$1.93K | ﹤0.01% | 333 |
|
|
2025
Q1 | $13.6K | Hold |
120
| – | – | ﹤0.01% | 298 |
|
|
2024
Q4 | $12.7K | Buy |
120
+20
| +20% | +$2.15K | ﹤0.01% | 323 |
|
|
2024
Q3 | $10.8K | Hold |
100
| – | – | ﹤0.01% | 319 |
|
|
2024
Q2 | $10.9K | Hold |
100
| – | – | ﹤0.01% | 326 |
|
|
2024
Q1 | $13.2K | Hold |
100
| – | – | ﹤0.01% | 292 |
|
|
2023
Q4 | $12.2K | Hold |
100
| – | – | ﹤0.01% | 306 |
|
|
2023
Q3 | $11.2K | Hold |
100
| – | – | ﹤0.01% | 316 |
|
|
2023
Q2 | $12.5K | Hold |
100
| – | – | ﹤0.01% | 306 |
|
|
2023
Q1 | $13.8K | Hold |
100
| – | – | ﹤0.01% | 372 |
|
|
2022
Q4 | $12.8K | Hold |
100
| – | – | ﹤0.01% | 378 |
|
|
2022
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 409 |
|
|
2022
Q2 | $11K | Hold |
100
| – | – | ﹤0.01% | 414 |
|
|
2022
Q1 | $13K | Sell |
100
-3
| -3% | -$362 | ﹤0.01% | 411 |
|
|
2021
Q4 | $13K | Sell |
103
-5
| -5% | -$654 | ﹤0.01% | 378 |
|
|
2021
Q3 | $15K | Buy |
+108
| New | +$15.9K | 0.01% | 317 |
|
|
2021
Q2 | – | Sell |
-108
| Closed | -$17K | – | 442 |
|
|
2021
Q1 | $17K | Buy |
+108
| New | +$16.7K | 0.01% | 315 |
|
|
2019
Q3 | – | Sell |
-103
| Closed | -$12K | – | 353 |
|
|
2019
Q2 | $12K | Hold |
103
| – | – | 0.01% | 257 |
|
|
2019
Q1 | $13K | Hold |
103
| – | – | 0.01% | 251 |
|
|
2018
Q4 | $10K | Hold |
103
| – | – | 0.01% | 263 |
|
|
2018
Q3 | $13K | Hold |
103
| – | – | 0.01% | 272 |
|
|
2018
Q2 | $11K | Sell |
103
-4,635
| -98% | -$504K | 0.01% | 270 |
|
|
2018
Q1 | $502K | Buy |
4,738
+82
| +2% | +$9.52K | 0.33% | 37 |
|
|
2017
Q4 | $569K | Buy |
4,656
+4,450
| +2,160% | +$503K | 0.35% | 33 |
|
|
2017
Q3 | $23K | Hold |
206
| – | – | 0.02% | 220 |
|
|
2017
Q2 | $26K | Hold |
206
| – | – | 0.02% | 211 |
|
|
2017
Q1 | $24K | Hold |
206
| – | – | 0.02% | 200 |
|
|
2016
Q4 | $21K | Buy |
+206
| New | +$22.1K | 0.02% | 208 |
|
Other funds holding ZBH
Mascoma Wealth Management's ZBH Position: Q2 2026 in Review
Mascoma Wealth Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 100 shares worth $8.61K. The position accounts for ﹤0.01% of the portfolio, ranked #336.
Mascoma Wealth Management first reported a position in ZBH in Q4 2016 and has held it in 32 quarters since. The position peaked at $569K in Q4 2017. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Mascoma Wealth Management held 100 shares of Zimmer Biomet worth $8.61K as of Q2 2026.
- Mascoma Wealth Management left its Zimmer Biomet share count unchanged in Q2 2026.
- Zimmer Biomet made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #336 holding.
- Mascoma Wealth Management first reported a position in Zimmer Biomet in Q4 2016 and has held it in 32 quarters since.
- Mascoma Wealth Management's Zimmer Biomet position peaked at $569K in Q4 2017.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.